Morguard Co. (TSE:MRC - Get Free Report) insider Sime Armoyan acquired 1,000 shares of the firm's stock in a transaction that occurred on Friday, October 9th. The stock was bought at an average price of C$113.00 per share, with a total value of C$113,000.00. Following the completion of the acquisition, the insider directly owned 1,480,423 shares of the company's stock, valued at C$167,287,799. This trade represents a 0.07% increase in their ownership of the stock.
Sime Armoyan also recently made the following trade(s):
- On Monday, October 5th, Sime Armoyan bought 2,400 shares of Morguard stock. The stock was bought at an average price of C$113.35 per share, for a total transaction of C$272,040.00.
- On Thursday, October 1st, Sime Armoyan bought 1,800 shares of Morguard stock. The stock was bought at an average price of C$113.97 per share, for a total transaction of C$205,146.00.
- On Monday, September 28th, Sime Armoyan bought 300 shares of Morguard stock. The shares were purchased at an average cost of C$114.25 per share, with a total value of C$34,275.00.
- On Thursday, September 24th, Sime Armoyan purchased 500 shares of Morguard stock. The shares were purchased at an average price of C$114.25 per share, with a total value of C$57,125.00.
- On Friday, September 25th, Sime Armoyan purchased 3,300 shares of Morguard stock. The stock was purchased at an average price of C$114.25 per share, for a total transaction of C$377,025.00.
- On Wednesday, September 23rd, Sime Armoyan purchased 900 shares of Morguard stock. The stock was purchased at an average price of C$114.25 per share, for a total transaction of C$102,825.00.
- On Monday, September 14th, Sime Armoyan acquired 300 shares of Morguard stock. The stock was purchased at an average cost of C$114.16 per share, for a total transaction of C$34,248.00.
- On Thursday, September 10th, Sime Armoyan acquired 300 shares of Morguard stock. The shares were purchased at an average price of C$114.00 per share, with a total value of C$34,200.00.
- On Wednesday, September 9th, Sime Armoyan acquired 1,500 shares of Morguard stock. The shares were purchased at an average price of C$114.00 per share, with a total value of C$171,000.00.
- On Tuesday, September 8th, Sime Armoyan bought 1,700 shares of Morguard stock. The shares were purchased at an average cost of C$114.14 per share, with a total value of C$194,038.00.
Morguard Trading Up 1.5%
TSE MRC traded up C$1.63 during mid-day trading on Friday, reaching C$113.85. 1,615 shares of the stock were exchanged, compared to its average volume of 3,104. The stock has a market cap of C$1.22 billion, a P/E ratio of 5.91 and a beta of 0.13. The company has a debt-to-equity ratio of 123.43, a current ratio of 0.42 and a quick ratio of 0.13. Morguard Co. has a one year low of C$111.55 and a one year high of C$127.40. The stock has a 50 day simple moving average of C$114.43 and a 200-day simple moving average of C$117.90.
Morguard (TSE:MRC - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The real estate investment trust reported C$7.93 earnings per share for the quarter. Morguard had a return on equity of 4.61% and a net margin of 18.49%. The firm had revenue of C$273.12 million during the quarter. On average, analysts anticipate that Morguard Co. will post 26.15 EPS for the current year.
About Morguard
(
Get Free Report)
Morguard Corporation is a real estate investment company listed on the Toronto Stock Exchange TSX: MRC. The company and its subsidiaries, Morguard REIT TSX: MRT.UN and Morguard North American Residential REIT TSX: MRG.UN, own a diversified portfolio of real estate assets across multiple classes, including office, industrial, retail, multi-suite residential and hotel. Morguard also provides real estate management services to institutional and other investors. As at September 30, 2025, Morguard's owned and managed portfolio of assets was valued at $19 billion.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Morguard, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morguard wasn't on the list.
While Morguard currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.